HCPCS Code J9217 | Description & Billing Guidelines

Report J9217 for 7.5 milligrams of Leuprolide Acetate for depot suspension when injected into a patient’s muscle to treat advanced prostate cancer symptoms.

What Is J9217?

One unit of HCPCS code J9217 represents 7.5 mg of Leuprolide Acetate for depot suspension. The route of administration is intramuscular, which is an injection into a muscle.

Leuprolide Acetate is a gonadotropin-releasing hormone (GnRH) agonist, which means leuprolide acetate acts like the hormone GnRH.

What Is Leuprolide Acetate?

Leuprolide Acetate for depot suspension helps treat advanced prostate cancer symptoms. It decreases the levels of certain hormones that the testes and ovaries release. Thus leuprolide acetate prevents the growth of certain tumors that need the presence of these hormones to develop.

Depot suspension indicates the drug formulation is a type that spreads slowly after injection.

Description

The official description of HCPCS code J9217 can be found underneath.

Short Description: “Leuprolide acetate suspnsion.”

Long Description: “Leuprolide acetate (for depot suspension), 7.5 mg.”

Pricing Indicator: 51

Code: O1E

Code Added: January 01, 1991

Last Changed: January 01, 1997

Billing Guidelines

Report one unit of HCPCS code J9217 for 7.5 mg of leuprolide acetate for depot suspension.

Leuprolide acetate for depot suspension is a generic drug. Brand names for leuprolide acetate include Lupron Depot®.

See J1950 for 3.75 mg leuprolide acetate for depot suspension; J9218 for each 1 mg of leuprolide acetate; and J9219 for leuprolide acetate implant, 65 mg.